• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

Siparex buys Winncare from IDI

  • Alessia Argentieri
  • Alessia Argentieri
  • 23 February 2021
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Private equity firm Siparex has acquired a majority stake in Winncare, a French manufacturer of medical beds, from IDI.

The deal values the company at around €100m, which would equate to 10x its EBITDA, according to press reports.

With this sale, IDI has reaped a 3.3x return on its investment and an IRR of 22%. The GP will reinvest in the company and retain a minority stake.

Winncare

  • DEAL:

    SBO

  • LOCATION:

    Paris

  • SECTOR:

    Medical equipment

  • FOUNDED:

    2004

  • TURNOVER:

    €75m (2020)

  • STAFF:

    450

  • VENDOR:

    IDI

Capza also participated in the deal alongside Siparex and has acquired a minority stake, while the management team, led by CEO Philippe Chene, has retained a holding of around 10%.

Siparex is deploying capital from its Siparex ETI 5 fund to finance the deal.

With the support of its new investors, Winncare plans to boost its organic and external growth through the development of cross-selling initiatives and geographical expansion, mainly in Europe.

Previous funding
Siparex acquired an 18% stake in hospital furniture manufacturer Médicatlantic and sold its shares to Milestone Capital in February 2004. The deal saw Milestone acquire a majority stake in Winncare for an undisclosed amount in a management buyout. Subsequently, Winncare acquired Asklé Santé, a provider of bed sore prevention products.

IDI invested in Winncare in 2014, when it deployed an equity ticket of around €17m and acquired a majority stake in the company from Milestone Capital. Debt to support the deal was arranged by CIC Ouest and Banque Populaire Atlantique, with mezzanine funding provided by LFPI Résilience.

Company
Founded in 2004 through the merger of Médicatlantic and Asklé Santé, Winncare designs and manufactures medical beds, pressure relieving mattresses, pressure ulcer prevention products and therapeutic cushions for elderly, ill, convalescent and disabled people – as well as hospital furniture.

Headquartered in Paris, the company has two production facilities in France and business units in Denmark, Poland, Spain, the UK and Tunisia.

Winncare employs 450 staff and sells its products to a customer base composed of 2,000 clients, primarily nursing homes and hospitals. The business generated revenues of around €75m in 2020.

People
Siparex ETI
– Alexandre Tremblin, Guillaume Rebaudet (directors).
Capza
– Christophe Karvelis-Senn (executive chair).
IDI – Marco de Alfaro (partner); Augustin Harrel-Courtès (investment director).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • France
  • Healthcare
  • Siparex
  • Capzanine
  • IDI
  • France

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013